Annual D&A
$236.59 M
+$107.75 M+83.64%
December 31, 2023
Summary
- As of February 7, 2025, PTCT annual depreciation & amortization is $236.59 million, with the most recent change of +$107.75 million (+83.64%) on December 31, 2023.
- During the last 3 years, PTCT annual D&A has risen by +$193.10 million (+444.01%).
- PTCT annual D&A is now at all-time high.
Performance
PTCT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$6.49 M
-$532.00 K-7.58%
September 30, 2024
Summary
- As of February 7, 2025, PTCT quarterly depreciation & amortization is $6.49 million, with the most recent change of -$532.00 thousand (-7.58%) on September 30, 2024.
- Over the past year, PTCT quarterly D&A has dropped by -$55.57 million (-89.55%).
- PTCT quarterly D&A is now -91.96% below its all-time high of $80.70 million, reached on December 31, 2023.
Performance
PTCT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$149.60 M
-$55.57 M-27.08%
September 30, 2024
Summary
- As of February 7, 2025, PTCT TTM depreciation & amortization is $149.60 million, with the most recent change of -$55.57 million (-27.08%) on September 30, 2024.
- Over the past year, PTCT TTM D&A has dropped by -$45.15 million (-23.18%).
- PTCT TTM D&A is now -39.96% below its all-time high of $249.16 million, reached on March 31, 2024.
Performance
PTCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
PTCT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +83.6% | -89.5% | -23.2% |
| 3 y3 years | +444.0% | -89.5% | -23.2% |
| 5 y5 years | +806.9% | -89.5% | -23.2% |
PTCT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +268.9% | -92.0% | at low | -40.0% | +133.3% |
| 5 y | 5-year | at high | +635.2% | -92.0% | at low | -40.0% | +364.9% |
| alltime | all time | at high | >+9999.0% | -92.0% | +1096.7% | -40.0% | >+9999.0% |
PTC Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.49 M(-7.6%) | $149.60 M(-27.1%) |
| Jun 2024 | - | $7.02 M(-87.3%) | $205.17 M(-17.7%) |
| Mar 2024 | - | $55.40 M(-31.4%) | $249.16 M(+5.3%) |
| Dec 2023 | $236.59 M(+83.6%) | $80.70 M(+30.1%) | $236.59 M(+21.5%) |
| Sep 2023 | - | $62.05 M(+21.7%) | $194.75 M(+16.5%) |
| Jun 2023 | - | $51.01 M(+19.1%) | $167.17 M(+15.0%) |
| Mar 2023 | - | $42.83 M(+10.2%) | $145.35 M(+12.8%) |
| Dec 2022 | $128.84 M(+100.9%) | $38.87 M(+12.7%) | $128.84 M(+18.4%) |
| Sep 2022 | - | $34.48 M(+18.2%) | $108.78 M(+19.5%) |
| Jun 2022 | - | $29.18 M(+10.9%) | $91.06 M(+18.5%) |
| Mar 2022 | - | $26.31 M(+39.9%) | $76.86 M(+19.8%) |
| Dec 2021 | $64.13 M(+47.5%) | $18.81 M(+12.3%) | $64.13 M(+11.1%) |
| Sep 2021 | - | $16.75 M(+11.8%) | $57.73 M(+9.7%) |
| Jun 2021 | - | $14.99 M(+10.3%) | $52.62 M(+10.0%) |
| Mar 2021 | - | $13.59 M(+9.6%) | $47.84 M(+10.0%) |
| Dec 2020 | $43.49 M(+35.1%) | $12.40 M(+6.5%) | $43.49 M(+7.7%) |
| Sep 2020 | - | $11.64 M(+14.0%) | $40.37 M(+9.5%) |
| Jun 2020 | - | $10.21 M(+10.6%) | $36.87 M(+7.3%) |
| Mar 2020 | - | $9.23 M(-0.5%) | $34.36 M(+6.8%) |
| Dec 2019 | $32.18 M(+23.4%) | $9.28 M(+13.9%) | $32.18 M(+8.4%) |
| Sep 2019 | - | $8.14 M(+5.7%) | $29.67 M(+3.7%) |
| Jun 2019 | - | $7.70 M(+9.1%) | $28.60 M(+5.5%) |
| Mar 2019 | - | $7.06 M(+4.3%) | $27.12 M(+4.0%) |
| Dec 2018 | $26.09 M | $6.77 M(-4.3%) | $26.09 M(+3.3%) |
| Sep 2018 | - | $7.07 M(+13.7%) | $25.25 M(-11.3%) |
| Jun 2018 | - | $6.22 M(+3.3%) | $28.48 M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $6.02 M(+1.4%) | $23.09 M(+30.6%) |
| Dec 2017 | $17.68 M(+437.4%) | $5.94 M(-42.3%) | $17.68 M(+40.8%) |
| Sep 2017 | - | $10.29 M(+1131.5%) | $12.56 M(+308.5%) |
| Jun 2017 | - | $836.00 K(+36.6%) | $3.07 M(+0.7%) |
| Mar 2017 | - | $612.00 K(-24.7%) | $3.05 M(-7.2%) |
| Dec 2016 | $3.29 M(+14.4%) | $813.00 K(0.0%) | $3.29 M(+0.5%) |
| Sep 2016 | - | $813.00 K(-0.2%) | $3.27 M(+1.6%) |
| Jun 2016 | - | $815.00 K(-4.0%) | $3.22 M(+4.2%) |
| Mar 2016 | - | $849.00 K(+6.5%) | $3.09 M(+7.5%) |
| Dec 2015 | $2.88 M(+28.7%) | $797.00 K(+4.9%) | $2.88 M(+9.7%) |
| Sep 2015 | - | $760.00 K(+10.9%) | $2.62 M(+9.0%) |
| Jun 2015 | - | $685.00 K(+8.0%) | $2.40 M(+5.4%) |
| Mar 2015 | - | $634.00 K(+17.0%) | $2.28 M(+2.1%) |
| Dec 2014 | $2.23 M(-6.7%) | $542.00 K(-0.2%) | $2.23 M(-1.9%) |
| Sep 2014 | - | $543.00 K(-3.4%) | $2.28 M(-2.0%) |
| Jun 2014 | - | $562.00 K(-4.4%) | $2.32 M(-1.5%) |
| Mar 2014 | - | $588.00 K(+0.5%) | $2.36 M(-1.5%) |
| Dec 2013 | $2.40 M(-11.4%) | $585.00 K(-0.7%) | $2.40 M(-2.9%) |
| Sep 2013 | - | $589.00 K(-1.3%) | $2.47 M(-3.1%) |
| Jun 2013 | - | $597.00 K(-4.5%) | $2.54 M(-3.2%) |
| Mar 2013 | - | $625.00 K(-4.6%) | $2.63 M(-2.8%) |
| Dec 2012 | $2.70 M(-5.8%) | $655.30 K(-1.8%) | $2.70 M(+32.0%) |
| Sep 2012 | - | $667.40 K(-2.1%) | $2.05 M(+48.3%) |
| Jun 2012 | - | $681.60 K(-2.6%) | $1.38 M(+97.4%) |
| Mar 2012 | - | $699.60 K | $699.60 K |
| Dec 2011 | $2.87 M | - | - |
FAQ
- What is PTC Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for PTC Therapeutics?
- What is PTC Therapeutics annual D&A year-on-year change?
- What is PTC Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for PTC Therapeutics?
- What is PTC Therapeutics quarterly D&A year-on-year change?
- What is PTC Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for PTC Therapeutics?
- What is PTC Therapeutics TTM D&A year-on-year change?
What is PTC Therapeutics annual depreciation & amortization?
The current annual D&A of PTCT is $236.59 M
What is the all time high annual D&A for PTC Therapeutics?
PTC Therapeutics all-time high annual depreciation & amortization is $236.59 M
What is PTC Therapeutics annual D&A year-on-year change?
Over the past year, PTCT annual depreciation & amortization has changed by +$107.75 M (+83.64%)
What is PTC Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PTCT is $6.49 M
What is the all time high quarterly D&A for PTC Therapeutics?
PTC Therapeutics all-time high quarterly depreciation & amortization is $80.70 M
What is PTC Therapeutics quarterly D&A year-on-year change?
Over the past year, PTCT quarterly depreciation & amortization has changed by -$55.57 M (-89.55%)
What is PTC Therapeutics TTM depreciation & amortization?
The current TTM D&A of PTCT is $149.60 M
What is the all time high TTM D&A for PTC Therapeutics?
PTC Therapeutics all-time high TTM depreciation & amortization is $249.16 M
What is PTC Therapeutics TTM D&A year-on-year change?
Over the past year, PTCT TTM depreciation & amortization has changed by -$45.15 M (-23.18%)